In this Feb. 27, 2020, file photo, the DoorDash app is shown on a smartphone in New York. (AP Photo, File)
One of the largest delivery platforms in the U.S., DoorDash is getting into the growing prescription drug delivery business through a partnership with wholesale giant Sam's Club.
“Our partnership with DoorDash to launch this new service allows us to not only give our members more convenient healthcare options, but also delivers on our commitment to their overall wellness needs,” said John McDowell, vice president of pharmacy operations and divisional merchandise at Sam’s Club, in a statement.
DoorDash is tapping Drive, its white-label fulfillment platform for merchants, to power the partnership, which emerged specifically to meet shifting consumer expectations amid COVID.
“Businesses have evolved amidst the pandemic to prioritize the safety of their communities and to adapt to new consumer habits, and our goal is to help merchants meet those demands in a way that’s best for their business,” said Christopher Payne, chief operating officer at DoorDash.
The coronavirus pandemic has accelerated the adoption of prescription drug delivery services. Pharmacies in particular have turned to third parties to compete with online retailers.
For DoorDash, the partnership comes as the platform teams up with other companies outside of the food category, including PetSmart, Macy's, Walgreens, CVS Pharmacy, and 7-Eleven.
DoorDash will provide same-day delivery across Sam Club's 500 locations.
Sam's Club is offering free delivery on their first two pharmacy orders until the end of the year and then charging a flat fee of $7.99 per order.
Federal Reserve governor Lisa Cook late Wednesday said she wouldn’t leave her post after Trump on social media called on her to resign over an accusation from one his officials that she committed mortgage fraud.
Explore how Guident’s cutting-edge software is shaping the future of autonomous vehicles with CEO Harald Braun. Safety, control & AI at the wheel of innovation.
Wondercraft co-founder Oskar Serrander discusses the booming AI audio industry, deepfake risks, and the growing market for synthetic, AI-generated content.
Comerica’s Chief Economist Bill Adams unpacks U.S. retail sales, job growth, and the resurgence of market volatility—and what it all signals for the economy.
Saar Yoskovitz, CEO of Augury, shares how the company delivers AI infrastructure that Fortune 500s rely on to boost efficiency, reliability, and scale.
